Community-acquired Pneumonia

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Community-acquired Pneumonia Due to Chlamydia Pneumoniae

Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia

Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia

Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

Frailty and Outcomes in Older Emergency Department Patients With Pneumonia

Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin

Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia

Discharge Stewardship in Children's Hospitals

CX-4945 in Viral Community Acquired Pneumonia

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

The Fever Clinic Acute Respiratory Cohort